0.00Open8.11Pre Close0 Volume73 Open Interest75.00Strike Price0.00Turnover0.00%IV0.33%PremiumMay 2, 2025Expiry Date7.84Intrinsic Value100Multiplier-2DDays to Expiry0.27Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma10.21Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet